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Abstract
Background. Hypertensive disorders during pregnancy have a detrimental effect on maternal
and fetal outcomes, causing low birth weights, preterm births, and stillbirths. During pregnancy,
hypertensive disorders affect up to 13% of all pregnancies and make up 10% of all maternal
mortality in the United States (Centers for Disease Control and Prevention [CDC], 2019).
Purpose. The purpose of this DNP project was to implement and standardize a high-risk
obstetrical initiative for hypertensive mothers. Summary of Evidence. Data suggest that
increased education and increased surveillance for high-risk obstetric patients decreases the need
for obstetric services and decreases the evolution of hypertensive disorders during
pregnancy. Objectives. This project aimed to decrease mother and infant morbidity and
mortality by standardizing an FQHC’s high-risk OB initiative, which attempted to provide faceto-face education with weekly telehealth follow-ups by a Registered Nurse in addition to regular
obstetrical appointments. Interventions. Interventions included implementing a standardized
enrollment and referral process, creating an electronic dashboard, and providing standardized inperson education and follow-up monitoring by a Registered Nurse. Increasing education and
weekly follow-up monitoring will assist in early recognition of hypertensive disease progression
and timely patient-specific interventions. Outcomes. The program increased patient program
enrollment by 940% and educated fifty-seven pregnant women on the signs and symptoms of
preeclampsia and eclampsia. Implications for Practice. This program provides a framework to
reduce perinatal and maternal mortality related to hypertensive disorders during pregnancy. This
program also strives to empower women during their pregnancy to be active participants in their
pre- and post- birth health.
Keywords: hypertensive disorders, pregnancy, high-risk pregnancy, telehealth
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Formalizing a High-Risk Obstetrical Initiative:
Focus—Hypertensive Disorders
Maternal and fetal outcomes have always been at the forefront of healthcare. Improving
maternal health is a key priority for the World Health Organization (WHO, 2019), an
organization dedicated to improving maternal health worldwide. According to WHO (2019),
maternal mortality rates are unacceptable, with data showing that roughly 295,000 women
worldwide died during their pregnancy or childbirth in 2017. WHO reports that many of these
deaths are preventable with adequate care and services. Unfortunately, in the United States,
maternal and fetal mortality and morbidity have continued to rise. The pregnancy-related
mortality rate in the United States has increased from 7.2 per 100,000 live births in 1987 to 17.3
in 2017 (Center for Disease Control and Prevention [CDC], 2020b). The rate of 17.3 deaths per
100,000 live births is more than double the rate of other developed countries (CDC, 2020a). In
countries like New Zealand, Norway, and the Netherlands, the maternal mortality ratio is 3 or
less per 100,000 live births. More specifically, hypertensive disorders during pregnancy make up
6.6% of maternal deaths in the United States. (CDC, 2020b). Hypertensive disorders during
pregnancy include gestational hypertension, chronic hypertension (pre-existing), preeclampsia,
and eclampsia. Hypertensive disorders affect one out of 17 pregnancies (CDC, 2020a).
Hypertensive disorders during pregnancy are known for increased maternal and fetal mortality.
Furthermore, hypertensive mothers are at significant risk for developing cardiovascular diseases
after their pregnancy and more severe hypertensive disorders with subsequent pregnancies.
Preeclampsia with severe symptoms has been identified as an independent risk factor to
developing cardiovascular disease, including coronary artery disease, hypertension,
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cerebrovascular accidents, and type 2 diabetes later in life (Paul et al., 2019). Preeclampsia alone
has increased by 25% from 1987-2004 (American College of Obstetricians and Gynecologists
[ACOG], 2020). Many of these hypertensive disorders can be treated before the disease process
evolves into a life-threatening situation for mother and infant. However, for many patients, these
disorders are not detected early or managed effectively because women cannot access care. Faceto-face education, telehealth follow-up, increased communication, and surveillance of
hypertensive patients during pregnancy are essential for detecting early signs and symptoms of
hypertensive disorders and establishing patient-specific interventions.
Statement of the Problem
Hypertensive disorders are increasing every year in the United States. According to the
CDC (2019), the rate of hypertensive disorders has almost doubled from 1993 to 2014, affecting
912 women per 10,000 live births. The number of women with pre-existing hypertension has
also increased significantly, almost tripling from 1993 to 2014, affecting 167 per 10,000 births
(CDC, 2019). Women in lower socioeconomic areas are at increased risk for developing
hypertensive disorders due to having more associated risk factors such as obesity, type 2
diabetes, sleep apnea, decreased awareness of signs and symptoms of hypertensive disorders, and
lack of access to care. When women develop hypertensive disorders, their overall health is at risk
during and after pregnancy. Currently, the only definitive treatment for preeclampsia is giving
birth. Different modalities and treatments are needed to combat these alarming increasing rates
and devastating maternal and perinatal outcomes.
Background
If not well controlled during pregnancy, hypertensive disorders place the mother and the
neonate at significant risk for complications that include eclampsia, restriction of fetal uterine
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growth, and fetal and maternal demise. Stillbirths are seven times more likely in hypertensive
mothers than mothers who are not hypertensive. Hypertensive mothers progressing into
preeclampsia is common, affecting 5%-8% of pregnancies in the United States (Bokslag et al.,
2016). Preeclampsia is defined as a systolic blood pressure >140 or diastolic blood pressure >90
after 20 weeks gestation, with the presence of one of the following: proteinuria (>300mg/24hrs),
maternal organ dysfunction, or uteroplacental dysfunction causing fetal growth restriction
(Bokslag et al., 2016). Women with pre-existing (chronic) hypertension are twice as likely to
progress into superimposed preeclampsia and be at increased risk for preterm births, perinatal
death, miscarriage, and abruption than preeclamptic women without chronic hypertension
(Sutton et al., 2018). Preeclampsia can occur quickly and suddenly, without notice. Therefore,
constant feedback between the patient and the healthcare team is essential for better patient
outcomes. Patients must also be aware of the signs and symptoms of preeclampsia and how to
escalate care if preeclamptic symptoms occur.
Significance
Hypertensive disorders are devastating because two individuals’ outcomes are affected,
not just one. Additionally, the rate of hypertensive disorders is increasing at an alarming rate.
According to Stevens et al. (2017), the diagnosis of preeclampsia, in particular, is rising faster
than diabetes, Alzheimer’s, ischemic heart failure, chronic kidney disease, and obesity. Despite
the high disease burden, current treatment options for preeclampsia are limited and the cost and
effect of preeclampsia on our healthcare system are staggering. Preeclampsia is associated with a
higher cost of birth, no matter the gestational age. Preeclampsia is also associated with premature
births, which are significantly more costly for infants born at a lower gestation age (Stevens et
al., 2017). In 2012, the total cost associated with preeclampsia in the U.S. healthcare system was
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$1.15 billion for infants and $1.03 billion for mothers, a combined cost of $2.18 billion (Stevens
et al., 2017).
There is a disparity among women in the United States affected by hypertensive disorders
and associated morbidity and mortality. Women with lower socioeconomic backgrounds and
from neighborhoods below the poverty line are more likely to be associated with severe maternal
mortality (Wang et al., 2020). Wang et al. (2020) also found that being of Hispanic ethnicity or
Black race, and having lower education and no insurance were significant factors associated with
higher maternal morbidity and mortality. Ethnic and racial minority women with multiple
chronic diseases also experience a substantial increase in severe maternal morbidity (Wang et al.,
2020). As a result, a gap in care is created; with hypertensive disorders substantially increasing
every year, more and more at-risk women could be fatally affected.
Needs Assessment
This high-risk OB quality improvement project took place at two Federally Qualified
Health Center (FQHC) women’s health clinics. These clinics were located on two campuses in a
south-central Texas metropolitan area. In addition to four Obstetrics-Gynecology (Ob-Gyn)
physicians and one registered nurse (RN), there were six medical assistants (MAs), two licensed
vocational nurses, one receptionist, and one office manager assigned to the two clinics. During a
pre-project organization assessment period, it was observed that the Ob-Gyn providers
inconsistently referred their high-risk hypertensive patients into the pre-standardized program,
with the referral process consisting of the providers messaging the RN regarding eligible
patients, when they remembered. It was also noted that because there was only one RN, the
education and follow-up of the mothers was sporadic. Lastly, it was determined that the RN
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documented the education and encounters in an Excel sheet and not the electronic health record
(EHR).
By formalizing this high-risk OB initiative focusing on hypertensive patients, it was
determined that the patients would benefit from having an RN provide face-to-face education
and frequent telephone follow-up, and this would facilitate the continuation of primary care after
delivery. This project aimed to standardize the referral and enrollment process, provide
consistent weekly follow-up monitoring and prompt face-to-face patient education after
enrollment, and streamline patient documentation for the high-risk hypertensive OB initiative.
This team-based OB-GYN project was based at the west campus clinic of the FHQC facility. The
care team comprised two of the four Ob-Gyn physicians, the RN, a receptionist, and the practice
manager. The two licensed vocational nurses participated in the team but were used by both the
east and west campus clinics.
Readiness for Change
The west campus clinic is intimately aware of the poor outcomes associated with elevated
blood pressure during pregnancy and the epidemic of hypertensive disorders during pregnancy
sweeping the country. Decreasing maternal and perinatal deaths and improving poor outcomes
are at the forefront of the clinic’s practice. The providers and staff are very engaged and
supported refining the program to make it more efficient. Once formalized, the clinic supported
expanding this initiative throughout the FQHC healthcare system. The standardization of the
hypertensive arm of this high-risk OB initiative provided data to improve the processes before
the expansion. Consequently, the clinic was highly motivated to decrease any barriers and assist
with implementing this project. Even though the staff, providers, and administration were

HYPERTENSIVE DISORDERS IN PREGNANCY

12

motivated to implement this project, change can be challenging, especially on a system and
process level, which is the foundation of this project.
Project Identification
Purpose
The purpose of this DNP project was to formalize and standardize a high-risk OB
initiative, which included (a) a standardized enrollment and referral process, (b) in-person and
telehealth education and follow-up monitoring by an RN, and (c) a standardized documentation
process. This project focused on the high-risk hypertensive OB patient population but included
other high-risk OB populations. This project aimed to decrease maternal and fetal morbidity and
mortality related to hypertensive disorders during pregnancy.
Outcomes
The anticipated outcomes for the project included (a) increasing the ease with which
patients were enrolled and how they were surveyed within the program, (b) growth in the number
of patients enrolled in the program, and (c) ensuring that the providers and the nurse understood
program procedures, education topics, and the documentation process. It was projected that
patients would have an increased understanding of overall wellness, including the signs and
symptoms of preeclampsia, and an appreciation of the importance of continued care after birth.
Objectives
The objectives for this evidence-based project were:
1. Educate 100% of providers, nurses, and MAs within the FQHC west campus Ob-Gyn
clinic regarding the obstetrical Initiative for high-risk hypertensive patients.
2. Enroll 95% of high-risk hypertensive OB patients in the obstetrical initiative for high-risk
hypertensive patients during the project implementation period.
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3. Close monitoring of 95% of the high-risk hypertensive OB patients during the project
implementation period per American College of Obstetricians and Gynecologists
(ACOG) guidelines. Criteria will be met if patients are seen or contacted by the RN
within 3 days of referral to the obstetrical Initiative for high-risk hypertensive patients
and receive at least one follow-up telehealth call per month up to the patient’s 6-week
postpartum visit.
4. Educate 100% of patients enrolled in the obstetrical Initiative for high-risk hypertensive
patients on gestational hypertension and preeclampsia symptoms during the project
implementation period.
5. Screen 100% of patients enrolled in the obstetrical initiative for high-risk hypertensive
patients using the ACOG Social Determinants of Health (SDoH) tool to identify needs
during the project implementation period.
6. Of those patients identified as having a positive SDoH screen, 95% will be provided
resources and referral to social/community services.
7. Refer 95% of patients enrolled in the obstetrical initiative for high-risk hypertensive
patients for continued care after the 6-week postpartum visit.
Summary and Strength of the Evidence
Significant risk factors are associated with the development of preeclampsia. However,
many women affected by preeclampsia are healthy nulliparous women with no known risk
factors (ACOG, 2020). According to ACOG (2020), relying on maternal symptoms for
preeclampsia can be problematic. Clinical signs and symptoms, such as headaches, are nonspecific and unreliable as a diagnostic criterion for preeclampsia with severe features (ACOG,
2020). It is imperative that a diagnostic approach is followed when clinical signs are less severe
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or not indicative of preeclampsia, especially if the gestational age is less than 20 weeks (ACOG,
2020). Women diagnosed with preeclampsia (without severe features) and women with
hypertension during pregnancy are managed similarly. However, to assume that hypertension
during pregnancy is benign or is less relevant than preeclampsia is incorrect (ACOG, 2020). Of
the women diagnosed with pregnancy-induced hypertension, 50% will develop a diagnosis that
is consistent with preeclampsia (ACOG, 2020). Disease progression occurs more often when the
hypertension diagnosis is made before 32 weeks of pregnancy (ACOG, 2020). What is required
with both diagnoses is enhanced surveillance to promote good outcomes and decrease maternal
and fetal risk. Screening methods, such as using biochemical markers and ultrasound to predict
preeclampsia development, are inaccurate and unreliable (ACOG, 2020). Strategies and
interventions to prevent preeclampsia have been studied for over 30 years, but no prevention
intervention has been noted to decrease the risk of developing preeclampsia (ACOG, 2020).
With regard to nutritional interventions, no evidence is noted to demonstrate the effectiveness of
vitamin supplementation or sodium restriction for decreasing the risk of preeclampsia (ACOG,
2020).
The nursing profession plays a vital role in the team-based patient-centered care team,
especially in a high-risk OB program. The RN enhances education, facilitates patient care
coordination, and acts as a liaison between the provider and patient. Swan et al. (2006) suggest
that the nurse’s most valuable asset is being the provider's eyes and ears. With a high-risk OB
population where an increase in surveillance is needed, an RN providing telephone follow-up
will only enhance team-based care, patient satisfaction, and maternal-fetal outcomes. Swan et al.
found that in six studies that used RN-led technology-based or telephone interventions to
promote education and provide counseling in heart-failure patients, outcomes improved. The
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results included a reduction in patient emergency department visits, decreased hospital
admissions, improved quality of life, improved self-care, and decreased mortality. In another
study, Muender et al. (2000) found that increasing surveillance by telephone calls 1 to 2 days a
week from 24 weeks until 37 weeks of gestation improved outcomes for the women and their
babies. Weekly calls consisted of health assessments, access to food and meals consumed, and
the use of prenatal vitamins. Muender et al. also concluded that women over the age of 18 had a
44% reduction in preterm births (<37 weeks) and significantly showed the cost-benefit of a
nursing intervention like telephone contact. Telephone contact is a relatively low cost and has
been an effective intervention to complement other interventions, such as home health care and
social support (Muender et al., 2000).
Most of the country is still overcoming barriers and decreased access to care related to
the COVID-19 pandemic. Mothers who are at risk for hypertensive disorders have had difficulty
accessing care at the height of the pandemic. These mothers need to be seen and evaluated in a
timely manner. The COVID-19 pandemic has helped open the door to making telemedicine more
mainstream. Perrin et al. (2020) states that health systems worldwide are adopting telemedicine
platforms and are employing them in new areas such as Ob-Gyn and primary care. The U.S.
Centers for Medicare & Medicaid Services (CMS) has significantly increased access to
telemedicine services, allowing for a broader range of providers to offer telemedicine services to
reach more patients (Perrin et al, 2020). With advancing technology and the overwhelming need
for a telemedicine platform, this widespread adoption by healthcare providers and healthcare
systems will facilitate healthcare delivery well into the 21st century (Perrin et al, 2020).
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Project Intervention Methods
Systems Interventions
Patients in the less formalized hypertensive high-risk OB program did not have a
standardized enrollment process; patient data was also not easily accessible within the EHR.
Often, high-risk hypertensive patients are overlooked or missed and not enrolled in the program.
System project interventions to remedy this include (a) a standardized referral and enrollment
process, (b) a standardized screening questionnaire, (c) a centralized dashboard for all patients
enrolled in the program, and (d) a nursing template for documentation. The MA was responsible
for the patient screening questionnaires, which identified eligible patients. If the MA noted a
positive screen, they would notify the patient’s provider. The provider would “task“ the RN for
patient enrollment, and the tasking tab within the EHR alerted the RN of the patient needing to
be enrolled. Non-billable dummy codes were developed and implemented to identify high-risk
patients and organize them within the dashboard. After applying the non-billable codes to the
patient, the codes allowed the RN and provider to survey the patient throughout their pregnancy,
identify what high-risk group they were in, and determine if their disease process resolved after
delivery. If needed, a patient-centered discussion between the provider and RN occurred to
determine patient enrollment. Then, the RN input the patient-specific enrollment and diagnosis
codes, adding the patient to the view-only high-risk OB dashboard. The dashboard effectively
allowed all staff to identify the enrolled patients quickly. The RN or provider also used the
dashboard to assess the key components of care, such as the patient’s last visit, gestational age,
previous vital signs and weight, and their assigned provider. The view-only dashboard updated
automatically once the patient was added.
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After enrollment, the RN had 3 days to initiate a telephone follow-up with the patient, if
the patient was not evaluated in the clinic. A manual for high-risk OB patients was also created
to use as a reference guide for the RN and staff. The manual included information on the referral
and enrollment process, patient education, documentation, weekly follow-up calls, and
community resources. This manual will assist with project sustainment.
Patient Interventions
Patient interventions included (a) face-to-face education regarding the signs and
symptoms of preeclampsia, eclampsia, stroke, and overall wellness; (b) pre-and post-education
questionnaires; (c) weekly follow-up telephone calls; (d) an SDoH screening with referral to
services when indicated; (e) periodic evaluation of the patient for normotensive blood pressure
until the 6-week postpartum appointment; and (f) facilitation of continued care after delivery
through a primary care referral, if needed. The formalizing of the OB program for high-risk
patients will assist with program expansion to all the FQHC women’s health clinics and assist
new personnel for project sustainment.
High-risk hypertensive patient face-to-face appointments were scheduled at the west
campus. Weekly follow-up calls were conducted to assess new or continued SDoH needs and
hypertensive disease progression signs and symptoms, and to reinforce education. Enrolled
patients were evaluated by periodic chart audits. The RN offered continued care, additional
resources, and further education at the 6-week postpartum follow-up appointment, if indicated. If
a patient missed the 6-week postpartum appointment, the RN initiated a telephone follow-up call.
Figure 1 outlines the system and patient interventions.
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Figure 1
High-Risk OB Initiative Flow Chart

Theoretical Framework
The Plan-Do-Study-Act framework was utilized for implementing this project, as this
was a systems and patient intervention process. Adjustments were necessary throughout project
implementation to meet patient and program objectives concisely and efficiently.
Setting and Population
The project was set at a FQHC system women’s health clinic on the west side of a southcentral Texas metropolis. Women enrolled in the program were diverse in ethnicity,
socioeconomic status and background; all enrolled women met the criteria and were considered
high-risk hypertensive patients.
Barriers and Facilitators
Barriers to the project’s success included (a) limited staffing, RN vacancy, and patients at
multiple clinic sites; (b) facilitating change in a large organization; and (c) staff resistance to
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change and provider hesitancy. Having one RN during the project implementation created a
significant barrier. A nurse at each site would have facilitated face-to-face education, increased
patient surveillance, and decreased lag in enrolling patients. The organization’s RN vacancy
decreased the ability to reach all enrolled patients promptly. The primary nurse position at the
clinic became vacant during the implementation period, and a newly graduated nurse took her
place. While this was initially a barrier, the newly hired nurse became a facilitator for this project
and quickly became a project champion.
The second barrier included working in a large organization. Interventions and changes to
implementation strategies needed approval from the administration, which created lag time and
delays in the project timeline.
A third barrier was the staff’s resistance to change and provider hesitancy. The RN was
primarily affected by the changes, and increased education was needed to initiate these changes.
Provider hesitancy in referring patients and tasking the RN for enrollment was another barrier.
Facilitators for the project included the Ob-Gyn director and the organization
administration, who had a commitment to have this program succeed and provide high-risk
women with quality team-based patient-centered care. Other facilitators included the partnership
between UIW and the organization. This partnership facilitated the formalization and
standardization of the organization’s program, enabling it to fulfil its mission of providing
comprehensive high-quality healthcare to the San Antonio area..
Evaluation Plan
To evaluate the percentage of eligible hypertensive high-risk OB patients enrolled in the
program, the number of eligible positive screens versus the number of patients enrolled in the
program were assessed during the project implementation period. Evaluating patient’s blood
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pressure trends was reviewed through patient chart audits and the patient’s dashboard data. A
chart audit was done to assess the number of enrolled patients who received face-to-face
education and weekly follow-ups. Pre- and post-questionnaires were collected to evaluate the
effectiveness of patient teaching. The SDoH screening questionnaire was also assessed to
determine the need for referrals to social or community services, followed by a chart audit to
determine if the patient received resources. A chart audit also evaluated for nursing template
documentation adherence and if the patients received education and referral to primary care
postpartum.
Ethical Consideration
The ethical considerations for this project included voluntary participation and
confidentiality. Patients involved with the project were informed that they could decline
participation in education and follow-up monitoring and that doing so would not impact their
eligibility for care. Personal and health-related information was needed to contact and assess
high-risk patients. The concern for confidentiality regarding this sensitive information was
mitigated by following HIPAA rules and regulations. The staff ensured that patient information
was kept safe and not shared within the healthcare team in an unsecured manner.
Results
The implementation of this project took place between March 19 and June 14, 2021. The
results for each of the objectives is shown in Figure 2.
The first objective was to educate 100% of providers, nurses, and MAs within the two
Ob-Gyn clinics. Project education was provided to 100% of the staff at each location, meeting
this objective. Education was provided during the morning huddle, 1 week before the project
implementation start date. One-on-one, in-person education to medical assistants, the RN, and
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providers was also offered as needed throughout project implementation. All participating staff
were receptive to program education. An educational email was sent to the providers and RN
related to enrollment codes and program processes, in conjunction with the in-person education.
This educational email provided a visual reference on how to enroll patients and the associated
non-billable dummy codes. All providers and the RN acknowledged the educational email.
Figure 2
OB High-Risk Initiative Result

Eligible Patients
Percent of Eligible Patients

100

80

100%

100%

100%

SDoH
Referrals

Referred to
Primary Care

90%
72%
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0
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Knowledge
Screens
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Note. This figure shows the results of program initiative objectives.
Enrolling 95% of eligible patients was the second objective. Eligible patients were
defined as the number of positive patient screens that met the program criteria. Hypertension
during pregnancy ICD-10 (International Classification of Diseases, Tenth Revision) code search
was performed during the 11-week project implementation period for the two clinical sites. The
search found that 90% of eligible women were enrolled in the program. The MAs were receptive
to screening and alerting the nurse and providers of positive screens. The nurse was able to enroll
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each patient who met the program criteria with positive screens daily. This objective was almost
successful due to the efforts of the patient-centered healthcare team.
The third objective was to have 95% of enrolled high-risk hypertensive OB patients have
increased surveillance, defined by the RN making initial contact within 3 days of patient
enrollment, either face-to-face or by phone call. Subsequently, the patient was to be contacted at
least once a month up to the patient’s 6-week postpartum visit. This objective was partially met.
A chart audit revealed that 100% of the enrolled patients received follow-up education at least
once during the implementation period. However, the criteria of initial contact within 3 days was
met by only 72% of the enrolled patients. Rapid enrollment of patients during the
implementation period, multiple referring providers, two clinic sites, and only one RN were
some of the factors that affected initial contact time. Even though this objective fell short, it did
provide evidence to support this project, positive patient outcomes, and the need for a facilitating
RN at each location.
The fourth objective was to educate 100% of enrolled high-risk hypertensive patients on
the signs and symptoms of preeclampsia and gestation or superimposed hypertension during
pregnancy. Chart audits were used to assess if the enrolled patients received this education. The
results found that 100% of the patients enrolled were educated not only on disease warning signs
and progression but also when to call 911, seek healthcare services, and where the hospital was
located. The pre and post-education questionnaires were audited to evaluate the impact of patient
education. Of the eligible patients enrolled in the program, 40% received a pre-and-post
questionnaire, and the average increase of knowledge was 15%.
The fifth objective stated that all enrolled patients would be screened with the ACOG
SDoH questionnaire. Due to the use of the PDSA cycle, this questionnaire was one of the last
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implementation intervention cycles. For the total implementation period, only 50% of the
patients enrolled in the program were screened.
The sixth objective was to provide services to those patients with a positive SDoH
questionnaire. A patient chart audit showed that, of the 29 patients screened, 15 patients were
identified as having a positive screen. All 15 patients were provided with the identified needed
resources.
The seventh objective stated that 95% of the patients enrolled would be referred to
primary care, if indicated at their 6-week postpartum visit. A chart audit showed that 100% of
patients who kept their 6-week postpartum visit appointment identified as needing primary care
services were referred.
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Discussions
Overall, this project was a success—the program assisted in empowering mothers to be
active participants in their health during and after pregnancy. Formalizing and standardizing the
program’s processes and the associated patient interventions were used to reach and educate the
women to the fullest capacity. Specific strengths of this quality improvement project were
formalizing and standardizing the clinic’s initial attempt at a program. New hires and the
administration have access to the devised program manual to help them understand how the
clinics educate and provide services to high-risk hypertensive mothers. A standardized RN
documentation template is also available, readily found within the EHR, facilitating data mining.
This data will assist in providing evidence on how effective this method of increased surveillance
is in assisting the patients, how effective patient education is, and what other interventions are
needed.
The most significant addition resulting from this project was the development and
implementation of the patient dashboard. This electronic dashboard allowed the providers,
nurses, and other involved staff to evaluate trends and patient-specific data, such as the patient’s
vitals, last appointment, next appointment, and when the previous RN visit occurred. The
dashboard and associated enrollment codes allow this program to work in conjunction with the
current EHR and provide sustainable, transparent monitoring for the staff and administration.
This dashboard was transformational in ensuring that the health status of this at-risk population
was closely observed during and after their pregnancy.
Associate changes seen were the rapid increase of patients enrolled in the program and
how receptive the patients were to participate in this program. It was noted that patients enjoyed
having access to an RN, discussing their questions and concerns about their pregnancy, and
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associated education. However, having two clinics with one RN managing both made
implementing the patient interventions difficult. Creating the patient-nurse bond was found to be
significantly more effective if done in person at initial contact. A trusting relationship is an
essential component when forming the patient health care team. It can be postulated that when
patients trust the RN and their healthcare team, they are more receptive to the education provided
and more likely to sustain lifestyle changes. While literature specific to formalizing and
standardizing a high-risk OB program focused on hypertensive OB patients was not found,
increased patient satisfaction when RNs are active members of the patient care team in primary
care is well documented (Swan, et al., 2006).
Limitations
Many limitations in project development and implementation were recognized. Working
with a large organization can be challenging, especially when a systems change is needed. Large
organizations require more time to access their system and arrange meetings with the appropriate
people regarding specific system interventions like the dashboard. Even though the IT
department was highly supportive and committed to this project, translating the needed patient
information into a unified dashboard was challenging. Multiple revisions and re-evaluations were
required to develop an effective patient dashboard, and the time required for each modification
was significant. The time necessary for development and revision of the dashboard was not
allocated in the project’s timeline, thus delaying some aspects of program implementation. A
free flow of exchanges with IT during development would have facilitated a timely program start
date and increased program clarity for staff and administration.
Another limitation was having only one RN to initiate this program. Having two RNs, one
at each site, would have increased the program’s reach and increased face-to-face patient
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education. Also, having an RN at both clinics would assist in championing the program, being an
ever-present reminder for staff to continue screening patients, and for the provider to task
eligible patients to the RN.
A third limitation was having the program snowball once the screening method was
implemented. The program grew significantly in a short amount of time, and the associated
workload was significant for one RN. Due to the increase in patients, the RN meeting project
objectives, like making initial contact within 3 days of enrollment and weekly follow-up calls,
was challenging.
Recommendations
Recommendations to improve project sustainability and growth to reach as many highrisk OB women include:
1. Implement an RN at each clinic. Having an RN at each site will facilitate prompt
face-to-face education and real-time patient enrollment. With multiple locations, the
providers have to task the RN, and they, in turn, must resolve the tasking, enroll the
patient, and make contact within 3 days. This process is delayed if the RN is at a
different location than the patient. If there was an RN at each location, the patient
could be seen the day they are enrolled. Also, the patient can have their questions
answered in person and be provided with educational handouts. This initial in-person
contact will also facilitate the patient’s trust in their health care team.
2. Provide an area where the RN can educate the patient. Currently, a patient flow issue
exists at both locations. After the provider sees the patient, the room must be cleaned
and prepared for the next patient. If the RN needs to educate the patient, then room
turnover is delayed. If the RN goes in before the provider, the provider must wait to
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see the patient, causing them to run behind. A designated area would allow the RN to
take their time when educating the patient and increase patient satisfaction. Also,
having a designated area avoids interference with patient flow and ensures that the
provider is not delayed and will continue to refer their patients to the program.
3. Continue with IT developers to make changes as needed to the enrollment process
and dashboard. As the program grows, changes will be needed to keep the enrollment
processes and dashboard current and user-friendly.
Sustainability
The sustainability of this program looks very promising. The medical director of the ObGyn clinics is invested in ensuring the program is sustainable, and her devotion will empower the
staff to sustain this project by answering questions, providing feedback, and being available for
unexpected issues. The medical director is also leading by example by advocating for project
implementation and sustainment. Her leadership will empower the staff to take the time
necessary to continue implementation and expand the program, even after project completion.
The staff is also aware of how important this project is to the medical director and to patients and
the avenues to take if any barriers arise during the sustainment phase. The medical director is
readily available and has an open-door policy for any questions or issues related to this project.
Having the medical director heavily invested also allows the administration and board of
directors to realize the project’s impact and benefit to patients, while also meeting organizational
goals, which include providing quality health care to an underserved population, providing
preventative health, and keeping patients healthy. Having the administration’s supports provides
an avenue for assistance if any barriers require administrative intervention. The administration is
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very interested in expanding the program; their goal is to broaden the OB initiative to all clinics
within the organization.
Addition support for sustainability is evident in that project barriers are quickly
identified, and suggestions from ancillary staff are well received. This project is heavily systemsbased and will need continuing modifications to the dashboard, enrollment codes, and processes
in the future. The interprofessional relationship that has been built during the project will be a
factor in its sustainability. The IT staff has been very receptive to assisting the medical director
and ensuring the system interventions are running smoothly. Any questions related to IT are
answered promptly.
Implications for Practice
A significant broad implication for practice is the importance of having a formalized
high-risk OB initiative that increases the surveillance of mothers at risk for harmful outcomes
due to hypertension during pregnancy and other high-risk conditions. This OB initiative
increased surveillance and education and promoted active patient participation in their
pregnancy. High-risk hypertensive mothers are more likely to have adverse outcomes than nonhypertensive moms. This program empowered the patient by enhancing patient education on
signs and symptoms of disease progression, having an RN available for questions, and providing
applicable avenues for resources. This program will assist in recognizing disease progression
earlier and improve mother and baby outcomes.
A second more practical implication is the standardization of processes for a local
initiative envisioned by the Ob-Gyn medical director for effective screening, enrollment,
education, and monitoring of patients at high risk for maternal and infant morbidity and
mortality. Upon starting the project, only 13 patients were enrolled in the high-risk OB initiative
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encompassing three different high-risk groups. After implementing appropriate screening and
enrollment strategies, enrollment expanded significantly. Specifically, high-risk hypertensive
patient enrollment increased by 940% during the project implementation period. Success was
possible due to the standardization and clear admission criteria defined in the high-risk program.
The patient-centered care team was able to identify, assess, and enroll patients successfully. The
participation of all members allowed for maximum enrollment, which optimized education,
utilization, and implementation of resources.
A third implication was the utilization of a patient-centered team-based approach. The
clinic is recognized as an FQHC, which endorses a patient-centered model. The patient-centered
approach has been recognized to assist with interprofessional communication, teamwork,
decreased patient wait times, the provision of more patient education, self-management support,
and the empowering of the patient to be an active member of their care team (Schottenfeld et al.,
2016). An essential first step is the clinic’s commitment to providing patient-centered teambased care, which involves viewing the patient as a knowledgeable and equal partner in their care
(Schottenfeld et al., 2016). This project implementation used this framework which encouraged
the patients to become active in their care and empower them through education to enact and
make sustainable lifestyle changes. Lifestyle changes will continue with their current pregnancy
and after delivery and provide optimal health for future pregnancies. The American Nurses
Association (2016) also endorses a patient-based team care approach and recognizes that the
team’s most important member is the patient. As a result, the team member who guides patient
care and related decision-making is the patient (American Nurses Associadtion, 2016). This
quality improvement project focused on actively listening to the patient and on patient education,
enabling the patient to make informed decisions during and after their pregnancy.
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The Essentials of Doctoral Education for Advanced Nursing Practice fully outlines the
role, scope, and leadership qualities of the doctoral-prepared nurse practitioner, regardless of
specialty or primary focus (American Association of Colleges of Nursing [AACN], 2006). This
quality improvement project fully enacted specific parts of the eight DNP Essentials, but two
DNP Essentials were the cornerstone and basis for development and successful project
implementation. These were Essential II: Organizational and Systems Leadership for Quality
Improvement and Systems Thinking, and Essential VI: Interprofessional Collaboration for
Improving Patient and Population Health Outcomes.
DNP Essential II: Organizational and Systems Leadership for Quality Improvement and
Systems Thinking allowed the conceptualization of new care delivery models which were
feasible, promoted safety, and were deeply rooted in nursing sciences (AACN, 2006). Focusing
on a target population allowed for an individualized patient education and care delivery model
that kept the patient’s cultural and economic perspectives in mind (AACN, 2006). System
improvements were made at a clinic level, enhancing sustainability and improving patient safety
and healthcare outcomes (AACN, 2006).
DNP Essential VI: Interprofessional Collaboration for Improving Patient and Population
Health Outcomes was instrumental in providing patient-specific care. The development of the
dashboard would not have been possible without the IT department listening to the needs
identified during this project. Also, the ongoing collaboration between the providers and nurse
was essential to decipher patient goals, provide education, and resolve any barriers or potential
barriers.
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Appendix B
High-Risk OB Screening Questionnaire

Have you ever been told you have diabetes by a doctor?

Yes

No

Have you ever been told you have high blood pressure?

Yes

No

Have you ever had a baby before 20 weeks, used
Makena (progestin) injections or had a cerclage?

Yes

No

Is BMI greater than 40?

Yes

No
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Appendix C
Nonbillable Dummy Codes

AVAILABLE CODES

HOW TO ADD THE CODES?
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Appendix D
SDoH Screening Questionnaire
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Appendix E
Hypertension during Pregnancy Pre-Post Questionnaire
1. A blood pressure over 140/90 is considered hypertension
True

False

2. High blood pressure may potentially cause harm to me or my baby.
True

False

3. Having high blood pressure increases my chance of developing preeclampsia.
True

False

4. Shortness of breath, a headache that won’t go away, and sudden swelling of face or hands
are all signs of preeclampsia.
True

False

5. I should call my doctor or 911 if I experience any of the above symptoms.
True

False
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